Volume 26, Number 5—May 2020
Synopsis
Epidemiology of Tick-Borne Relapsing Fever in Endemic Area, Spain
María Carmen Domínguez
, Salvador Vergara, María Carmen Gómez, and María Esther Roldán
, Salvador Vergara, María Carmen Gómez, and María Esther Roldán
Table 1
Characteristics of 98 patients with tick-borne relapsing fever, Spain*
| Variable | Value |
|
|---|---|---|
| Median age, y (IQR) |
29 (17–46) |
|
| Sex | ||
| M | 55 (56.1) | |
| F |
43 (43.9) |
|
| Town of residence | ||
| Osuna | 40 (40.8) | |
| Ecija | 20 (20.4) | |
| Other |
38 (38.8) |
|
| Risk activities | ||
| Farming | 15 (15.3) | |
| Hiking | 10 (10.2) | |
| Hunting |
3 (3.1) |
|
| Contact with rodents | 13 (13.3) | |
| Tick bite | 17 (17.3) | |
| JHR, n = 79 | 8 (10.1) | |
| Median time before diagnosis, d (IQR) | 3 (2–5) | |
| Hospitalized | 56 (57.1) | |
| Median length of hospital admission, d (IQR) |
5 (4–6) |
|
| Antimicrobial drug treatment | ||
| Tetracycline | 79 (80.6) | |
| Macrolides | 18 (18.4) | |
| Cephalosporin | 9 (9.2) | |
| Penicillin G |
2 (2) |
|
| Duration of antimicrobial therapy, d (IQR) | 10 (7–14) | |
| Death |
0 |
|
| *Values are no. (%) except as indicated. IQR, interquartile range; JHR, Jarisch-Herxheimer reaction. †Except where noted. | ||
Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.